Pfizer Takes Action Against Generics At FDA

Law360, New York (February 8, 2006, 12:00 AM EST) -- Generic versions of Pfizer Inc.’s antibiotic Zithromax made by Teva Pharmaceuticals U.S.A. and Novartis subsidiary Sandoz Inc. do not accurately describe the drugs' active ingredients and are a danger to consumers, according to petition filed by Pfizer with the U.S. Food and Drug Administration Wednesday.

The petition is the latest in a series of maneuvers that have targeted the generic companies’ at-risk launch of the drug, which the FDA approved for generic manufacture in November 2005. The main patent for Zithromax expired on Nov. 1, although...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.